Proliferative glomerulonephritis with monoclonal immunoglobulin IgG1-κ deposition in a patient with type 1 diabetes: a case report and literature review - Scorecard - MDSpire

Proliferative glomerulonephritis with monoclonal immunoglobulin IgG1-κ deposition in a patient with type 1 diabetes: a case report and literature review

  • By

  • Xi Li

  • Xiaoyan Zhang

  • Xinjun Dai

  • Yan Zhang

  • Tian Lan

  • Jian Li

  • Minghui Wu

  • Tianhang Jia

  • Jie Li

  • June 15, 2026

  • 0 min

Share

Clinical Scorecard: Monoclonal IgG1-κ Deposition in Proliferative Glomerulonephritis: A Case Study in a Type 1 Diabetes Patient with Literature Insights

At a Glance

CategoryDetail
Condition
Key MechanismsMonoclonal immunoglobulins deposited in the mesangial area of the glomeruli and capillary walls cause complement activation, glomerular inflammation, and hyperplasia.
Target Population
Care Setting

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

      Management

        Monitoring & Follow-up

          Risks

            Patient & Prescribing Data

            Clinical Best Practices

              Related Resources & Content

                Original Source(s)

                Proliferative glomerulonephritis with monoclonal immunoglobulin IgG1-κ deposition in a patient with type 1 diabetes: a case report and literature review

                • by Xi Li, Xiaoyan Zhang, Xinjun Dai, Yan Zhang, Tian Lan, Jian Li, Minghui Wu, Tianhang Jia, Jie Li

                • June 15, 2026

                Related Content

                Infections and CAR-T cells for the treatment of lymphoid malignancies: a narrative review

                Comparative efficacy and safety of etoposide plus PEG-rhG-CSF versus etoposide plus G-CSF for haematopoietic stem cell mobilisation in patients with multiple myeloma and lymphoma

                Predicting CAR-T outcomes in R/R DLBCL: a multicenter real-world study of a 5-index model